AxoGen Inc - AXGN Net Assets per Single Share

Graphic logo of Axogen Corp (AXGN)

The price history of AxoGen, Inc. (AXGN) is presented below, with the indicator standing at 4.76. AxoGen, Inc. (AXGN) enjoys an impeccable reputation among neurosurgeons due to a substantial body of clinical data. The business is based on developing advanced nerve fiber regeneration methods through investments in tissue engineering. Demand for such procedures is independent of market fluctuations, guaranteeing the company high resilience to economic crises.

Axogen Corp - AXGN Net Assets per Share (period 07/04/2022 - 10/27/2026)

Summary analytical data breakdowns for axogeninc.com (AXGN)

- price and consensus price forecast:
Stock Price Axogen Corp|AXGN - Analyst Target Range
- market capitalization data:
Market Value AxoGen, Inc.|AXGN - Business Value
- book capitalization data:
Net Assets per Single Share Axogen|AXGN - Book Valuation of Business|Market Value to Book Value Ratio axogeninc.com|AXGN - Total Asset Value of Company
- debt and liquidity data:
Total Debt to Capital AxoGen, Inc.|AXGN - Long-Term Liabilities to Capital|Short-Term Debt to Capital Axogen|AXGN - Company Total Debt|Debts to Book Capitalization AxoGen, Inc.
Analysis of all company metrics:Axogen Corp AXGN
Finished products of axogeninc.com

Long-term asset screening requires a balance between the margin of safety and growth potential. Book value per share determines the portion of net assets attributable to a single security after deducting all liabilities. For AxoGen, Inc. (AXGN), this foundation is strengthened by scaling operations with Avance nerve grafts. Current market capitalization reflects actual asset coverage. The BVPS trend clearly demonstrates the resilience of the company's financial framework.

Competitors of AxoGen, Inc. (AXGN)

Book Value per Share BSX|EW: Book Value of One Share|Net Assets per Single Share ResMed Inc.|PODD (insulet.com) - Equity per Share|ZBH: Net Assets per Single Share|Net Assets per Share COO|ALGN - Net Assets per Single Share|Share Book Value NuVasive (GMED)|TMDX: Book Value per Share|Net Asset Value per Share atecspine.com ATEC|AORT: Book Value per Share|ENOV - Accounting Value per Share|Integra - Book Value per Share|Establishment Labs Inc (ESTA) - Net Assets per Share|BBNX (Beta Bionics Inc) - Book Value per Share|Book Value per Share IRMD|Net Assets per Single Share Embecta (EMBC)|Net Assets per Single Share Tandem Diabetes Care Inc (TNDM)|Book Value per Share SIBN|OFIX - Net Assets per Share|Accounting Value per Share Bioventus Inc.|KIDS - Share Book Value|Book Value per Share TMCI|Blade Air Mobility (SRTA) - Net Asset Value per Share|Book Value per Share Carlsmed Corp (CARL)|Equity per Share RxSight Ophthalmic (RXST)|ClearPoint Neuro, Inc. (CLPT) - Accounting Value per Share|Accounting Value of a Share STXS (stereotaxis.com)|Neuronetics - Net Assets per Single Share|Accounting Value per Share Sight Sciences Inc. SGHT|OBIO (Orchestra BioMed, Inc.) - Book Value per Share|ANIK - Net Asset Value per Share|Book Value per Share InspireMD, Inc.|Jin Medical (ZJYL) - Equity per Share|VANI: Book Value per Share|Net Assets per Share Xtant Medical Inc|Book Value per Share NMTC (NeuroOne Corp)|Accounting Value per Share modular-medical.com (MODD)|Book Value per Share MYO (Myomo, Inc.)|envoymedical.com - Book Value per Share|VVOS - Net Assets per Single Share|enVVeno Medical Corporation (NVNO) - Net Assets per Single Share|Accounting Value per Share sintx.com SINT|Tenon Medical Inc (TNON) - Accounting Value of a Share|Book Value per Share LFWD (ReWalk Robotics Ltd.)|Net Asset Value per Share AMIX|IVF: Net Assets per Single Share|Book Value of One Share Bone Biologics Corp. BBLG|Accounting Value per Share AXNX (Axonics Modulation Technologies)|Book Value per Share Biolase Inc. BIOL|Book Value per Share DYNT (Dynatronics Corp.)|FNA: Net Assets per Share|Net Assets per Single Share invobioscience.com (INVO)